Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Seattle, Washington 98122


Purpose:

Stress Management interventions have been shown to decrease cancer-related distress, foster emotional growth and improve immune functioning during treatment for breast cancer. This study will evaluate an online version of a stress management intervention for women with early stage breast cancer. Each chapter of the 10-week intervention include self-assessment and targeted feedback, education, interactive learning exercises -- all tailored to the needs of women with early stage breast cancer. In addition, guided writing exercises will promote emotional expression and a discussion board will encourage group support. The web-based intervention is being evaluated in a randomized clinical trial with a sample of 120 women with early stage breast cancer. Women will be randomly assigned to use the 10-week intervention with biweekly telephone assessments or to the telephone assessments alone.


Study summary:

Stress Management interventions have been shown to decrease cancer-related distress, foster emotional growth and improve immune functioning during treatment for breast cancer. This study will evaluate an online version of a stress management intervention for women with early stage breast cancer. Each chapter of the 10-week intervention include self-assessment and targeted feedback, education, interactive learning exercises -- all tailored to the needs of women with early stage breast cancer. In addition, guided writing exercises will promote emotional expression and a discussion board will encourage group support. The web-based intervention is being evaluated in a randomized clinical trial with a sample of 120 women with early stage breast cancer. Women will be randomly assigned to use the 10-week intervention with biweekly telephone assessments or to the telephone assessments alone.


Criteria:

Inclusion Criteria: - Diagnosis of stage 0, I, II or III breast cancer within past 18 months - Elevated stress, distress or negative mood - Access at least 1.5 - 2 hours per week to a computer with audio capabilities that is connected to the internet - Ability to read, write, and speak English at a sixth grade level - Access to a telephone and an active e-mail account Exclusion Criteria: - Cancer diagnosis is a recurrence - Diagnosis of schizophrenia - Use of anti-psychotic medication - Diagnosis of bipolar disorder without use of mood stabilizing medication


NCT ID:

NCT01335152


Primary Contact:

Principal Investigator
Kelly M Carpenter, PhD
Talaria, Inc


Backup Contact:

N/A


Location Contact:

Seattle, Washington 98122
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.